Skip to main content
Top

Current Cardiology Reports

Issue 8/2018

Content (10 Articles)

Determinants of Achieved LDL Cholesterol and “Non-HDL” Cholesterol in the Management of Dyslipidemias

  • Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)

Chris J. Packard

HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?

  • Open Access
  • Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)

I. Karalis, J. W. Jukema

Cardiovascular and Renal Outcomes of Newer Anti-Diabetic Medications in High-Risk Patients

  • Ischemic Heart Disease (D Mukherjee, Section Editor)

Lima Lawrence, Venu Menon, Sangeeta Kashyap

Gender Disparities in Presentation, Management, and Outcomes of Acute Myocardial Infarction

  • Ischemic Heart Disease (D Mukherjee, Section Editor)

Matthew Liakos, Puja B. Parikh

Use of Interleukin-1 Blockers in Pericardial and Cardiovascular Diseases

  • Pericardial Disease (AL Klein, Section Editor)

Giacomo Emmi, Maria Letizia Urban, Massimo Imazio, Marco Gattorno, Silvia Maestroni, Giuseppe Lopalco, Luca Cantarini, Domenico Prisco, Antonio Brucato

Update on Incorporating Biomarkers with Imaging Findings for the Detection and Management of Cardiotoxicity

  • Cardio-Oncology (SA Francis and RB Morgan, Section Editors)

Neha Quatromoni, Marielle Scherrer-Crosbie

Cardiovascular Autonomic Dysfunction in Patients with Cancer

  • Cardio-Oncology (SA Francis and RB Morgan, Section Editors)

Ben G. T. Coumbe, John D. Groarke

Cardiomyocyte Proliferation for Therapeutic Regeneration

  • Regenerative Medicine (SM Wu, Section Editor)

John P. Leach, James F. Martin

Long-term Management of the Arterial Switch Patient

  • Congenital Heart Disease (RA Krasuski, Section Editor)

Jared Kirzner, Altaf Pirmohamed, Jonathan Ginns, Harsimran S. Singh

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME